• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10621
Device Problem Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/26/2022
Event Type  malfunction  
Event Description
It was reported that the balloon ruptured occurred.A 3.00 x 28mm synergy ii drug eluting stents was selected for use in the percutaneous coronary intervention (pci) procedure.The target lesion was none tortuous and none calcified lesion.The synergy stent was unable to deploy, when the physician removed the device from patient body the balloon had a hole at the proximal end and the balloon leak at 4 atmospheres.The procedure was completed successfully with another of the synergy stent device was used.There was no patient compilations reported.
 
Event Description
It was reported that the balloon ruptured occurred.A 3.00 x 28mm synergy ii drug eluting stents was selected for use in the percutaneous coronary intervention (pci) procedure.The target lesion was none tortuous and none calcified lesion.The synergy stent was unable to deploy, when the physician removed the device from patient body the balloon had a hole at the proximal end and the balloon leak at 4 atmospheres.The procedure was completed successfully with another of the synergy stent device was used.There was no patient compilations reported.
 
Event Description
It was reported that the balloon ruptured occurred.A 3.00 x 28mm synergy ii drug eluting stents was selected for use in the percutaneous coronary intervention (pci) procedure.The target lesion was none tortuous and none calcified lesion.The synergy stent was unable to deploy, when the physician removed the device from patient body the balloon had a hole at the proximal end and the balloon leak at 4 atmospheres.The procedure was completed successfully with another of the synergy stent device was used.There was no patient compilations reported.
 
Manufacturer Narrative
Device evaluated by manufacturer: the returned product consisted of a 3.00 x 28mm synergy stent delivery system (sds).Visual examination of the stent found signs of stent damage.Stent struts in the proximal section of the stent was found to be flared and distal stent struts were found to be lifted from their crimped position.The undamaged stent od (outer diameter) was measured using snap gauge and the result was within maximum crimped stent profile measurement.The returned device was attached to an encore inflation unit and positive pressure was applied in an attempt to inflate the balloon.Liquid was observed to be leaking from a balloon pinhole located in the proximal balloon cone at 3.7 cm proximal to the distal tip.The rated burst pressure of this synergy device is 16 atm.Inflation device was verified before and after use using a druck pressure gauge.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube identified no issues with the hypotube of this device.A visual examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.Inspection of the remainder of the device presented no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13508245
MDR Text Key285620953
Report Number2134265-2022-01385
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/19/2023
Device Model Number10621
Device Catalogue Number10621
Device Lot Number0027981129
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/26/2022
Initial Date FDA Received02/10/2022
Supplement Dates Manufacturer Received04/20/2022
Supplement Dates FDA Received04/26/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/19/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-